PTPA and chronic myelogenous leukemia, BCR-ABL1 positive: A few years ago, Neviani el al. identified protein phosphatase 2A (PP2A), a tumor suppressor able to decrease survival and self-renewal capacity of quiescent CML-LSCs, but not of normal quiescent HSCs (13).